Credence Genomics Ltd., Sri Lanka’s premier specialised DNA diagnostics services provider has achieved yet another first by being published in the acclaimed BioMed Central (BMC) Infectious Diseases publication.With their innovative range of specialised DNA diagnostic tests, Credence Genomics has reached out to benefit the medical community in Sri Lanka and in the region, with the uncompromised guarantee of accuracy and speed of test reports by achieving unparalleled benchmarks. Metagenomics based results show a 91.8% concordance rate for culture positive specimens and 52.8% concordance rate with culture negative samples. 10.3% of specimens were also positive for fungal species which was not investigated by culture. Specificity and sensitivity for metagenomics analysis is 91.8 and 52.7% respectively.
